Nanalysis Net Receivables vs Common Stock Analysis

NSCI Stock

CAD 0.33 0.01 2.94%

Nanalysis Scientific financial indicator trend analysis is infinitely more than just investigating Nanalysis Scientific Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nanalysis Scientific Corp is a good investment. Please check the relationship between Nanalysis Scientific Net Receivables and its Common Stock accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanalysis Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Net Receivables vs Common Stock

Net Receivables vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nanalysis Scientific Corp Net Receivables account and Common Stock. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Nanalysis Scientific's Net Receivables and Common Stock is 0.84. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Common Stock in the same time period over historical financial statements of Nanalysis Scientific Corp, assuming nothing else is changed. The correlation between historical values of Nanalysis Scientific's Net Receivables and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Nanalysis Scientific Corp are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Net Receivables i.e., Nanalysis Scientific's Net Receivables and Common Stock go up and down completely randomly.

Correlation Coefficient

0.84

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Net Receivables

Common Stock

Most indicators from Nanalysis Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nanalysis Scientific Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanalysis Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Selling General Administrative is likely to drop to about 8 M in 2024. Tax Provision is likely to drop to about (11.6 K) in 2024

	2021	2022	2023	2024 (projected)
Gross Profit	10.2M	10.5M	4.0M	6.8M
Total Revenue	16.0M	24.8M	28.5M	14.7M

Gross Profit Total Revenue

Nanalysis Scientific fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Other Liab	Net Debt	Non Current Assets Total	Common Stock Shares Outstanding	Non Current Liabilities Total
Total Assets		0.32	0.89	0.98	0.88	-0.75	0.97	0.41	0.86	0.62	0.88	0.98	-0.17	0.84	0.86	0.73	0.95	-0.7	0.98	0.88	0.92	0.89	0.61	0.98	0.93	0.77
Other Current Liab	0.32		0.2	0.42	0.38	-0.01	0.4	0.66	0.52	-0.01	0.11	0.3	-0.51	0.14	0.52	-0.08	0.45	-0.54	0.47	0.38	0.53	0.35	0.03	0.19	0.12	0.05
Total Current Liabilities	0.89	0.2		0.84	0.93	-0.95	0.9	0.22	0.93	0.89	0.85	0.89	-0.15	0.99	0.92	0.94	0.85	-0.56	0.85	0.95	0.81	0.97	0.86	0.91	0.96	0.96
Total Stockholder Equity	0.98	0.42	0.84		0.91	-0.68	0.93	0.58	0.88	0.56	0.84	0.92	-0.24	0.78	0.88	0.65	0.98	-0.77	0.98	0.9	0.94	0.88	0.57	0.92	0.86	0.71
Net Tangible Assets	0.88	0.38	0.93	0.91		-0.85	0.86	0.5	0.97	0.8	0.85	0.81	-0.33	0.91	0.97	0.83	0.92	-0.75	0.87	1.0	0.91	0.97	0.83	0.83	0.88	0.89
Retained Earnings	-0.75	-0.01	-0.95	-0.68	-0.85		-0.75	-0.01	-0.84	-0.98	-0.8	-0.75	0.16	-0.98	-0.83	-0.99	-0.68	0.46	-0.67	-0.87	-0.69	-0.89	-0.96	-0.8	-0.91	-1.0
Accounts Payable	0.97	0.4	0.9	0.93	0.86	-0.75		0.42	0.88	0.64	0.87	0.97	-0.08	0.84	0.88	0.73	0.95	-0.65	0.94	0.88	0.92	0.91	0.61	0.94	0.93	0.77
Cash	0.41	0.66	0.22	0.58	0.5	-0.01	0.42		0.45	-0.04	0.29	0.3	-0.37	0.15	0.45	0.0	0.65	-0.57	0.49	0.47	0.59	0.42	0.04	0.23	0.2	0.08
Other Assets	0.86	0.52	0.93	0.88	0.97	-0.84	0.88	0.45		0.8	0.78	0.83	-0.39	0.91	1.0	0.79	0.89	-0.74	0.88	0.98	0.91	0.97	0.81	0.82	0.85	0.87
Long Term Debt	0.62	-0.01	0.89	0.56	0.8	-0.98	0.64	-0.04	0.8		0.73	0.62	-0.19	0.94	0.79	0.96	0.58	-0.4	0.55	0.83	0.61	0.84	0.99	0.67	0.82	0.98
Net Receivables	0.88	0.11	0.85	0.84	0.85	-0.8	0.87	0.29	0.78	0.73		0.84	0.07	0.83	0.78	0.8	0.86	-0.67	0.8	0.84	0.87	0.84	0.72	0.85	0.93	0.81
Inventory	0.98	0.3	0.89	0.92	0.81	-0.75	0.97	0.3	0.83	0.62	0.84		-0.12	0.83	0.83	0.73	0.9	-0.62	0.95	0.83	0.87	0.87	0.59	0.98	0.94	0.76
Other Stockholder Equity	-0.17	-0.51	-0.15	-0.24	-0.33	0.16	-0.08	-0.37	-0.39	-0.19	0.07	-0.12		-0.17	-0.39	-0.04	-0.21	0.38	-0.26	-0.32	-0.33	-0.23	-0.29	-0.13	-0.07	-0.17
Total Liab	0.84	0.14	0.99	0.78	0.91	-0.98	0.84	0.15	0.91	0.94	0.83	0.83	-0.17		0.91	0.97	0.79	-0.53	0.78	0.94	0.77	0.96	0.92	0.86	0.94	0.99
Deferred Long Term Liab	0.86	0.52	0.92	0.88	0.97	-0.83	0.88	0.45	1.0	0.79	0.78	0.83	-0.39	0.91		0.79	0.89	-0.74	0.88	0.98	0.91	0.96	0.81	0.82	0.85	0.87
Short Long Term Debt	0.73	-0.08	0.94	0.65	0.83	-0.99	0.73	0.0	0.79	0.96	0.8	0.73	-0.04	0.97	0.79		0.67	-0.38	0.64	0.85	0.64	0.88	0.94	0.78	0.9	0.99
Total Current Assets	0.95	0.45	0.85	0.98	0.92	-0.68	0.95	0.65	0.89	0.58	0.86	0.9	-0.21	0.79	0.89	0.67		-0.75	0.94	0.92	0.95	0.91	0.6	0.87	0.86	0.72
Short Term Debt	-0.7	-0.54	-0.56	-0.77	-0.75	0.46	-0.65	-0.57	-0.74	-0.4	-0.67	-0.62	0.38	-0.53	-0.74	-0.38	-0.75		-0.77	-0.72	-0.85	-0.65	-0.46	-0.6	-0.58	-0.49
Intangible Assets	0.98	0.47	0.85	0.98	0.87	-0.67	0.94	0.49	0.88	0.55	0.8	0.95	-0.26	0.78	0.88	0.64	0.94	-0.77		0.87	0.92	0.87	0.55	0.94	0.86	0.7
Common Stock	0.88	0.38	0.95	0.9	1.0	-0.87	0.88	0.47	0.98	0.83	0.84	0.83	-0.32	0.94	0.98	0.85	0.92	-0.72	0.87		0.9	0.99	0.85	0.84	0.9	0.91
Property Plant Equipment	0.92	0.53	0.81	0.94	0.91	-0.69	0.92	0.59	0.91	0.61	0.87	0.87	-0.33	0.77	0.91	0.64	0.95	-0.85	0.92	0.9		0.88	0.64	0.84	0.85	0.72
Other Liab	0.89	0.35	0.97	0.88	0.97	-0.89	0.91	0.42	0.97	0.84	0.84	0.87	-0.23	0.96	0.96	0.88	0.91	-0.65	0.87	0.99	0.88		0.83	0.86	0.92	0.92
Net Debt	0.61	0.03	0.86	0.57	0.83	-0.96	0.61	0.04	0.81	0.99	0.72	0.59	-0.29	0.92	0.81	0.94	0.6	-0.46	0.55	0.85	0.64	0.83		0.64	0.8	0.96
Non Current Assets Total	0.98	0.19	0.91	0.92	0.83	-0.8	0.94	0.23	0.82	0.67	0.85	0.98	-0.13	0.86	0.82	0.78	0.87	-0.6	0.94	0.84	0.84	0.86	0.64		0.95	0.8
Common Stock Shares Outstanding	0.93	0.12	0.96	0.86	0.88	-0.91	0.93	0.2	0.85	0.82	0.93	0.94	-0.07	0.94	0.85	0.9	0.86	-0.58	0.86	0.9	0.85	0.92	0.8	0.95		0.91
Non Current Liabilities Total	0.77	0.05	0.96	0.71	0.89	-1.0	0.77	0.08	0.87	0.98	0.81	0.76	-0.17	0.99	0.87	0.99	0.72	-0.49	0.7	0.91	0.72	0.92	0.96	0.8	0.91

Click cells to compare fundamentals

Nanalysis Scientific Account Relationship Matchups

Nanalysis Scientific fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	18.3M	24.0M	37.8M	69.9M	53.8M	31.5M
Other Current Liab	705K	2.6M	2.0M	810K	428K	406.6K
Total Current Liabilities	1.6M	5.6M	8.6M	13.5M	14.6M	15.3M
Total Stockholder Equity	15.1M	14.3M	24.0M	35.1M	23.5M	17.8M
Net Tangible Assets	7.9M	14.5M	13.8M	22.0M	25.2M	26.5M
Retained Earnings	(4.2M)	(7.9M)	(9.7M)	(18.8M)	(35.0M)	(33.2M)
Accounts Payable	678K	2.6M	4.4M	5.8M	5.1M	3.0M
Cash	6.6M	3.2M	10.4M	3.5M	759K	721.1K
Other Assets	3.8M	5.9M	12.1M	12.5M	14.4M	15.1M
Long Term Debt	1.0M	2.8M	2.7M	3.8M	12.6M	13.2M
Net Receivables	2.6M	1.8M	5.0M	6.1M	8.3M	4.4M
Inventory	857K	2.8M	3.7M	7.4M	5.8M	3.2M
Other Stockholder Equity	817.7K	997.1K	215K	714K	642.6K	553.5K
Total Liab	3.2M	9.6M	13.8M	22.3M	30.3M	31.9M
Deferred Long Term Liab	3.8M	5.9M	12.1M	12.5M	14.4M	15.1M
Short Long Term Debt	116K	209K	1.9M	3.7M	6.5M	6.8M
Total Current Assets	10.2M	9.4M	20.8M	22.0M	17.9M	12.8M
Intangible Assets	6.5M	12.7M	14.1M	26.6M	15.9M	11.1M
Common Stock	10.0M	18.3M	20.7M	31.3M	36.0M	37.8M
Property Plant Equipment	1.1M	1.6M	2.0M	2.5M	2.9M	1.6M
Non Current Assets Total	8.1M	14.6M	17.0M	47.9M	35.9M	23.7M
Common Stock Shares Outstanding	62.4M	66.0M	77.2M	94.4M	101.9M	85.0M
Non Current Liabilities Total	1.6M	3.3M	5.2M	8.8M	15.7M	16.5M
Capital Lease Obligations	371K	752K	1.3M	3.3M	2.9M	1.6M
Net Invested Capital	16.3M	17.4M	28.6M	42.6M	42.5M	28.7M
Capital Stock	18.3M	20.7M	31.3M	49.0M	53.2M	33.4M
Net Working Capital	8.5M	3.0M	12.1M	8.4M	3.3M	3.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Nanalysis Stock Analysis

When running Nanalysis Scientific's price analysis, check to measure Nanalysis Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanalysis Scientific is operating at the current time. Most of Nanalysis Scientific's value examination focuses on studying past and present price action to predict the probability of Nanalysis Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanalysis Scientific's price. Additionally, you may evaluate how the addition of Nanalysis Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC